Asia Pacific Type 2 Diabetes Mellitus Treatment Market Size & Outlook
The type 2 diabetes mellitus treatment market in Asia Pacific is expected to reach a projected revenue of US$ 22,706.7 million by 2030. A compound annual growth rate of 7.6% is expected of Asia Pacific type 2 diabetes mellitus treatment market from 2024 to 2030.
Revenue, 2023 (US$M)
$13,581.1
Forecast, 2030 (US$M)
$22,706.7
CAGR, 2024 - 2030
7.6%
Report Coverage
Asia Pacific
Related Markets
Asia Pacific type 2 diabetes mellitus treatment market highlights
- The Asia Pacific type 2 diabetes mellitus treatment market generated a revenue of USD 13,581.1 million in 2023.
- The market is expected to grow at a CAGR of 7.6% from 2024 to 2030.
- In terms of segment, insulin was the largest revenue generating drug class in 2023.
- Insulin is the most lucrative drug class segment registering the fastest growth during the forecast period.
Asia Pacific data book summary
| Market revenue in 2023 | USD 13,581.1 million |
| Market revenue in 2030 | USD 22,706.7 million |
| Growth rate | 7.6% (CAGR from 2024 to 2030) |
| Largest segment | Insulin |
| Fastest growing segment | Insulin |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Insulin |
| Key market players worldwide | AstraZeneca PLC, Boehringer Ingelheim, Daiichi Sankyo Co Ltd, Eli Lilly and Co, Merck & Co Inc, Novartis AG ADR, Novo Nordisk A/S ADR, Sanofi SA, Takeda Pharmaceutical Co Ltd |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 23.6% of the global type 2 diabetes mellitus treatment market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 22,706.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Type 2 diabetes mellitus treatment market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Daiichi Sankyo Co Ltd | View profile | 17435 | 3-5-1, Nihonbashi-honcho, Chuo-ku, Tokyo, Japan, 103-8426 | https://www.daiichisankyo.com |
| Takeda Pharmaceutical Co Ltd | View profile | 49095 | 1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, Japan, 103-8668 | https://www.takeda.com |
| AstraZeneca PLC | View profile | 89900 | 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA | https://www.astrazeneca.com |
| Novo Nordisk A/S ADR | View profile | 66015 | Novo Alle 1, Bagsvaerd, Denmark, 2880 | https://www.novonordisk.com |
| Eli Lilly and Co | View profile | 43000 | Lilly Corporate Center, Indianapolis, IN, United States, 46285 | https://www.lilly.com |
| Boehringer Ingelheim | View profile | 10001+ | Ingelheim Am Rhein, Rheinland-Pfalz, Germany, Europe | https://www.boehringer-ingelheim.com/ |
| Merck & Co Inc | View profile | 72000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | https://www.merck.com |
| Sanofi SA | View profile | 87994 | 46, avenue de la Grande Armée, Paris, France, 75017 | https://www.sanofi.com |
| Novartis AG ADR | View profile | 76057 | Lichtstrasse 35, Basel, Switzerland, 4056 | https://www.novartis.com |
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
